Study of Retinal Function Using Electroretinogram in Regular Alcohol Users

NCT ID: NCT03818971

Last Updated: 2021-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-13

Study Completion Date

2021-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alcohol is a major public health problem and its neurotoxic effects are, among other things, responsible for altering the functioning of cerebral neurotransmission pathways.

The retina is an anatomical and developmental extension of the central nervous system. It is composed of several layers of retinal neurons that share similar anatomical and functional properties with brain neurons. Retinal neurons are notably equipped with a complex system of neurotransmission constituted by the main neurotransmitters that are involved in the central effects of alcohol: glutamate, dopamine, serotonin ... The retina is used here as a site of indirect investigation for abnormal central neurotransmission pathways following regular alcohol use. It is recognized to date as a good site for investigating central abnormalities in neuropsychiatric and addictive disorders.

The objective of this project is to study the retinal function using electroretinogram (ERG) in regular alcohol users to isolate potential markers of cerebral neurotransmission abnormalities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

retina AND electroretinogram

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

mono centric study, in parallel groups, controlled, non-randomized and open
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

alcohol consumption with alcohol use disorder (AUD)

subjects with regular alcohol consumption with AUD according to the DSM 5 without any other substance use disorder (except alcohol) without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized

Group Type EXPERIMENTAL

electroretinogram (flash, pattern and multifocal)

Intervention Type OTHER

we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG

alcohol consumption without alcohol use disorder

subjects with regular alcohol consumption without AUD according to the DSM 5 without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized

Group Type OTHER

electroretinogram (flash, pattern and multifocal)

Intervention Type OTHER

we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG

no alcohol consumption

subjects without alcohol consumption without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized

Group Type OTHER

electroretinogram (flash, pattern and multifocal)

Intervention Type OTHER

we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electroretinogram (flash, pattern and multifocal)

we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged between 18 and 35 years
* alcohol use disorder according to the DSM 5
* affiliation to a social security scheme

Exclusion Criteria

* psychoactive substance consumption (other than alcohol)
* psychiatric disease in progress according to the DSM 5
* neurologic disease in progress
* mental impairment making it difficult or impossible to participate to the study
* major under guardianship or curatorship or under safeguarding of justice
* pregnant women or feeding
* people in emergency situation
* participation to another interventional study
* retinal disease in progress
* chronic glaucoma
* ophtalmic disease affecting the visual acuity
* ocular infection in progress
* urinary positive drug check the day of the inclusion
* postive Breathalyser the day of the inclusion
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Psychothérapique de Nancy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas SCHWITZER

Role: PRINCIPAL_INVESTIGATOR

Centre Psychothérapique de Nancy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Psychothérapique de Nancy

Laxou, Nancy, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IDRCB 2018-A02336-49

Identifier Type: OTHER

Identifier Source: secondary_id

RIPH 2018-02

Identifier Type: -

Identifier Source: org_study_id